McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q1 2026 holdings
- Shares (Q1 2026)
- 353
- Value
- $173.5K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 353 | $173.5K | <0.1% | +56+18.9% | Added | Holders |
| Q4 2025 | 297 | $172.1K | <0.1% | +100+50.8% | Added | Holders |
| Q3 2025 | 197 | $95.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 197 | $79.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 197 | $98.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 197 | $102.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 197 | $121.9K | <0.1% | −40−16.9% | Reduced | Holders |
| Q2 2024 | 237 | $131.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 237 | $137.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 237 | $125.8K | <0.1% | −11−4.4% | Reduced | Holders |
| Q3 2023 | 248 | $125.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 248 | $129.4K | <0.1% | −1−0.4% | Reduced | Holders |
| Q1 2023 | 249 | $143.5K | <0.1% | +1+0.4% | Added | Holders |
| Q4 2022 | 248 | $136.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 248 | $126.0K | <0.1% | +150+153.1% | Added | Holders |
| Q2 2022 | 98 | $53.0K | <0.1% | −51−34.2% | Reduced | Holders |
| Q1 2022 | 149 | $88.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 149 | $100.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 149 | $85.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 149 | $75.0K | <0.1% | +92+161.4% | Added | Holders |
| Q1 2021 | 57 | $26.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.